Ameritox and Millennium compete to screen urine specimens
for drugs. They contract with healthcare
providers. Ameritox alleged that
Millennium falsely advertised its services and also engaged in unfair business
practices, including “providing illegal inducements to garner business,
performing medically unnecessary confirmatory testing, assisting healthcare
providers in acquiring an improper ownership interest in purportedly
independent businesses, and not collecting legally required co-payments and
deductibles.”
Millennium moved to dismiss Ameritox’s false advertising,
tortious interference, and unfair competition claims; the interesting part is the false advertising aspect.
The false advertising covered multiple types of conduct,
including printed ads—billing letters—provided by Millennium to providers for distribution
to patients. Millennium allegedly
informed potential customers that its corporate policy was to not collect from
patients the difference between the amount Millennium billed for its services
and the amount the patients' insurance companies agreed to pay; Millennium also
advertised that it would not require patients to pay deductibles or co-pays. These
ads were allegedly false and misleading to three groups: those enrolled in
Medicare who are not required to pay any co-pay or deductible; those enrolled
in Florida Medicaid who are required to pay only a $1 co-payment; and those
enrolled in private insurance programs that include the services that
Millennium provides within a patient's annual deductible. Thus, Millennium advertised an illusory
benefit—and it was also illegal to waive those payments, so Millennium
allegedly got customers by falsely representing that this was legal.
Millennium also distributed an allegedly misleading press
release in which its CEO advocated for Medicare to reimburse healthcare
providers at a higher rate for drug screening, claiming that Millennium had no
vested interest in advocating for this change. In fact, Millennium’s motives were not
altruistic because such a change would make it money.
The other allegations described various schemes to encourage
providers to engage in unnecessary, duplicative, and otherwise illegal billing
and to suggest that these techniques weren’t illegal; among other things,
Millennium allegedly encouraged providers to invest in supposedly independent
labs that would forward samples to Millennium for additional testing. Providers had an incentive to choose
Millennium in the mistaken belief that its schemes were legal.
First, Millennium argued that it hadn’t engaged in “commercial
advertising or promotion” by disseminating its representations sufficiently to
the relevant purchasing public. Alleged
dissemination of billing letters to thousands of providers and, through them,
to thousands of patients was sufficient.
As for the other representations, they were allegedly disseminated to
thousands of providers in several different states, which was also enough.
Falsity: As to the press release, Ameritox argued that it
was literally false to say “Millennium as a corporation has no financial stake
in this argument.” Given the allegation that Millennium's business model is
premised on generating increased revenue for healthcare providers partly through
Medicare reimbursements, the court agreed. Likewise, where Ameritox alleged
that Millennium represented that the conduct it was advocating “was in
compliance with federal and state laws” and was otherwise proper, that combined
will allegations that the conduct was actually illegal was sufficient to allege
literal falsity.
What about statements encouraging conduct but not explicitly
telling providers that the conduct was legal?
Ameritox argued that these were false by necessary implication where the
conduct was, in fact, illegal. Though
the Eleventh Circuit hasn’t formally adopted the doctrine of falsity by
necessary implication, many other circuits have, as have district courts in the
circuit. So the question was whether the targeted audience would receive the
message “the conduct we’re advocating is legal” as if it had been stated. Ameritox alleged that consumers chose
Millennium mistakenly believing that its representations promoted legal conduct—and
that makes a lot of sense to me; while we’ve seen plenty of systemic
corruption, I at least want to believe that a pitch saying “let’s commit
Medicare fraud!” would have been received very differently.
Assuming that there was a necessary implication of legality,
Millennium argued that Ameritox hadn’t conclusively demonstrated illegality and
thus falsity. However, on a motion to
dismiss, the court determined that allegations of illegality were sufficient.
Similarly, Ameritox sufficiently alleged that the billing
letter misleadingly touted an illusory benefit, since some patients weren’t
required to pay for Millennium’s services in the first place. If Millennium actually didn’t charge co-pays,
then saying it wouldn’t seek payment from patients couldn’t be literally
false. But the allegation of implicit
falsity was sufficient.
What about deception or tendency to deceive? Ameritox sufficiently specified how consumers
were or were likely to be deceived: because of mistaken beliefs in the legality
and propriety of Millennium’s billing schemes.
Also, literal falsity doesn’t require evidence of consumer deception,
and at the pleading stage, plaintiffs need not provide evidence of consumer
deception for misleadingness either.
Materiality: Ameritox alleged that the legality and
propriety of billing arrangements were material to purchasing decisions. That was enough on a motion to dismiss. The press release was different, but the
court accepted that providers could be, at least in part, persuaded to choose
Millennium because of a deceptive implication of Millennium’s magnaminity.
Millennium argued that its statements about legality or
propriety were non-actionable opinions.
Statements by laypersons purporting to interpret law are opinion unless
a court or agency of competent jurisdiction has clearly and unambiguously ruled
on the matter at the time of the alleged misstatements. But Ameritox provided support for its
arguments that the practices discussed violated established law at the time of
the ads, with a combination of agency reports, statutes, regulations, and case
law.
No comments:
Post a Comment